ArticleClinical and experimental medicine2025
Clinicopathological profile of basal cell carcinoma: a retrospective study from Limpopo province, South Africa.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- β-Catenin-Associated Wnt Signaling and Tumor Microenvironment Markers in Basal Cell Carcinoma Subtypes.Journal of clinical medicine · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basal cell carcinoma is a non-melanoma skin cancer arising from basal epidermal keratinocytes. Its incidence is on the rise in the African continent and has been reported as the common skin malignancy worldwide, with a male predominance. The BCC subtypes are divided into low- and high-risk types based on prognostic characteristics. This study aimed to describe the demographic and clinicopathological characteristics of basal cell carcinoma cases from a predominantly native African population.A retrospective descriptive case series reviewed histopathological reports and archival slides of 86 basal cell carcinoma cases diagnosed at the National Institute for Occupational Health (NIOH), Pathology Division, from 1 January 2017 to 31 June 2021. Data were retrieved from the laboratory information system, captured into a Microsoft Excel spreadsheet and then analysed using STATA v.18.The mean age for the 86 study cases was 61 years, with a higher prevalence of BCC in females (64%). Most BCC lesions, 46 (53.5%), were located at the head and neck region. The low-risk nodular (45.4%; n = 39), the high-risk infiltrative (6.0%; n = 6) and basosquamous (5.8%; n = 5) were the most diagnosed BCC histopathological subtypes. Solar damage was recorded in (53.5%; n = 46) cases. Solar elastosis was associated with BCC subtype (odds ratio, 2.56; 95% CI, 1.0-6.3; P = 0.041).Basal cell carcinoma was more common in African females in their sixth decade. Age and nodular histopathological subtypes are consistent with most previous studies. These study findings highlight the growing incidence of BCC in the African population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.